IND enabling development of CF-296, a lysin for the treatment of invasive staphylococcus aureus (s. Aureus) infections

Ended Project Grant Awarded Last action

Award ID
W81XWH1910139
Recipient
Awarding agency
Obligated
$5,203,776

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Yonkers, NY 10701, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$2,018,621
Amendment $0
Amendment $0
Amendment Covid- the purpose of this modification is to extend the period of performance by one year at no additional cost to the government per the recipient s… $0
Amendment $0
Amendment This modification is to make a correction regarding submission of quarterly technical reports. Submission of the reports is due within 30 days of the ending… $0
Original award $7,222,397

Quick answers

Who received award W81XWH1910139?

W81XWH1910139 was awarded to Contrafect Corporation by Defense Health Agency (Department of Defense) on June 1, 2019.

How much is award W81XWH1910139 worth?

$5,203,776 has been obligated on W81XWH1910139.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login